In the total population, no significant trend could be observed in the T2DM group [APC: −0.50% (−1.12–0.10%), p = 0.0991], while a decreasing trend was found in the Non-Diab group [APC: −1.79% (−2.07–−1.52%), p < 0.0001].
As for the Non-Diab group, we found an increasing trend for non-Hodgkin lymphoma [APC: 3.23% (1.25–5.15%), p = 0.0011] and thyroid [APC: 3.07% (0.67–5.38%), p = 0.0112] cancers, and a decreasing trend for gallbladder [APC: −6.04% (−8.98–−3.20%), p < 0.0001], stomach [APC: −5.25% (−7.12–−3.43%), p < 0.0001], colorectal [APC: −1.17% (−1.99–−0.37%), p = 0.